| Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer (NCT05136846) | Ohio State University Comprehensive Cancer Center | 2021-12-06 |
| A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence (NCT04298606) | Roswell Park Cancer Institute | 2021-11-22 |
| Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial (NCT04789681) | M.D. Anderson Cancer Center | 2021-07-20 |
| Effects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung Cancer (NCT04857697) | Mayo Clinic | 2021-07-01 |
| Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment (NCT04862195) | Blue Note Therapeutics | 2021-05-15 |
| Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer (NCT04705025) | Jonsson Comprehensive Cancer Center | 2021-04-08 |
| Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer (NCT03819296) | M.D. Anderson Cancer Center | 2021-02-21 |
| Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study (NCT05022394) | M.D. Anderson Cancer Center | 2021-02-18 |
| Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer (NCT04751747) | Rutgers, The State University of New Jersey | 2021-02-11 |
| NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer (NCT04505267) | M.D. Anderson Cancer Center | 2021-02-10 |
| Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer (NCT04348292) | Emory University | 2021-01-22 |
| Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients (NCT04310020) | National Cancer Institute (NCI) | 2021-01-13 |
| Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer (NCT04214262) | National Cancer Institute (NCI) | 2020-08-13 |
| Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung Cancer (NCT04946279) | OHSU Knight Cancer Institute | 2020-08-07 |
| Bintrafusp Alfa Before Surgery for the Treatment of Untreated Resectable Non-small Cell Lung Cancer (NCT04560686) | M.D. Anderson Cancer Center | 2020-08-05 |
| Family Caregivers in Underserved Populations Providing Complex Cancer Care (NCT05213078) | City of Hope Medical Center | 2020-07-15 |
| Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer (NCT04428905) | City of Hope Medical Center | 2020-07-11 |
| Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) (NCT04267848) | National Cancer Institute (NCI) | 2020-06-16 |
| Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer (NCT04061590) | University of California, San Francisco | 2020-05-29 |
| Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial (NCT03801902) | National Cancer Institute (NCI) | 2019-10-28 |
| Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes (NCT04183218) | Mayo Clinic | 2019-09-23 |
| Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer (NCT04013542) | M.D. Anderson Cancer Center | 2019-09-13 |
| Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study (NCT04430725) | M.D. Anderson Cancer Center | 2019-08-07 |
| Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) (NCT03811002) | National Cancer Institute (NCI) | 2019-07-26 |
| Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer (NCT03995667) | OHSU Knight Cancer Institute | 2019-06-11 |
| Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer (NCT04067830) | Roswell Park Cancer Institute | 2019-03-20 |
| Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their Caregivers (NCT03902535) | City of Hope Medical Center | 2019-03-08 |
| Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers (NCT03948100) | M.D. Anderson Cancer Center | 2018-12-20 |
| Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients (NCT03867916) | University of California, San Francisco | 2018-12-13 |
| Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing Treatment (NCT03731585) | M.D. Anderson Cancer Center | 2018-11-15 |
| Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study (NCT03634241) | M.D. Anderson Cancer Center | 2018-11-13 |
| Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery (NCT03132532) | Mayo Clinic | 2017-07-31 |